(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Brilliant Acquisition Corporation, Cemtrex, and BiondVax Pharmaceuticals Ltd..

Rank Financial Asset Price Change Updated (EST)
1 Brilliant Acquisition Corporation (BRLIR) 0.25 21.6% 2021-12-08 19:32:11
2 Cemtrex (CETXW) 0.14 13.31% 2021-12-09 05:08:07
3 BiondVax Pharmaceuticals Ltd. (BVXV) 1.73 8.12% 2021-12-09 01:12:26
4 Clearside Biomedical (CLSD) 3.26 7.95% 2021-12-09 09:09:05
5 Baudax Bio (BXRX) 0.38 6.56% 2021-12-09 01:15:09
6 Boxlight Corporation (BOXL) 1.59 6% 2021-12-08 19:11:08
7 BioXcel Therapeutics (BTAI) 23.79 5.41% 2021-12-09 01:08:13
8 Restoration Hardware Holdings (RH) 608.01 5.38% 2021-12-09 14:45:52
9 Catalyst Biosciences (CBIO) 1.24 5.08% 2021-12-09 03:11:10
10 CVS Health (CVS) 97.65 4.88% 2021-12-09 14:40:39

The three most active and biggest losers today are Ringcentral, GameStop, and Cemtrex.

Rank Financial Asset Price Change Updated (EST)
1 Ringcentral (RNG) 181.18 -15.54% 2021-12-09 14:46:03
2 GameStop (GME) 153.43 -11.64% 2021-12-09 14:42:04
3 Cemtrex (CETXP) 2.10 -11.02% 2021-12-09 05:07:07
4 Kinross Gold (KGC) 5.24 -10.95% 2021-12-09 14:43:18
5 Dare Bioscience (DARE) 1.92 -9.62% 2021-12-09 15:09:10
6 Coinbase (COIN) 261.44 -9.06% 2021-12-09 14:49:51
7 QuantumScape (QS) 24.11 -8.1% 2021-12-09 14:49:31
8 VerifyMe (VRME) 3.41 -7.34% 2021-12-09 13:52:50
9 Wayfair (W) 221.58 -6.89% 2021-12-09 14:48:14
10 Chiasma (CHMA) 3.76 -6% 2021-12-09 07:06:06

Most Active Winners today

1. Brilliant Acquisition Corporation (BRLIR) – 21.6%

NASDAQ Composite ended the session with Brilliant Acquisition Corporation rising 21.6% to $0.25 on Thursday, after five consecutive sessions in a row of losses. NASDAQ Composite slid 1.71% to $15,517.37, after three successive sessions in a row of gains, on what was an all-around down trend trading session today.

Brilliant Acquisition Corporation’s last close was $0.25, 0% under its 52-week high of $0.25.

Brilliant Acquisition Corporation’s Stock Yearly Top and Bottom Value

Brilliant Acquisition Corporation’s stock is valued at $0.25 at 16:32 EST, under its 52-week low of $0.25.

More news about Brilliant Acquisition Corporation.

2. Cemtrex (CETXW) – 13.31%

NASDAQ Composite ended the session with Cemtrex jumping 13.31% to $0.14 on Thursday, after five successive sessions in a row of losses. NASDAQ Composite slid 1.71% to $15,517.37, after three sequential sessions in a row of gains, on what was an all-around negative trend exchanging session today.

Cemtrex’s last close was $0.14, 0.14% under its 52-week high of $0.14.

Cemtrex’s Stock Yearly Top and Bottom Value

Cemtrex’s stock is valued at $0.14 at 16:32 EST, above its 52-week high of $0.14.

More news about Cemtrex.

3. BiondVax Pharmaceuticals Ltd. (BVXV) – 8.12%

NASDAQ Composite ended the session with BiondVax Pharmaceuticals Ltd. jumping 8.12% to $1.73 on Thursday while NASDAQ Composite dropped 1.71% to $15,517.37.

Volume

Today’s last reported volume for BiondVax Pharmaceuticals Ltd. is 113707 which is 47.61% above its average volume of 77030.

BiondVax Pharmaceuticals Ltd.’s last close was $1.73, 76.04% under its 52-week high of $7.22.

BiondVax Pharmaceuticals Ltd.’s Stock Yearly Top and Bottom Value

BiondVax Pharmaceuticals Ltd.’s stock is valued at $1.73 at 16:32 EST, way under its 52-week high of $7.22 and way above its 52-week low of $1.56.

BiondVax Pharmaceuticals Ltd.’s Moving Average

BiondVax Pharmaceuticals Ltd.’s worth is way under its 50-day moving average of $2.10 and way below its 200-day moving average of $2.82.

More news about BiondVax Pharmaceuticals Ltd..

4. Clearside Biomedical (CLSD) – 7.95%

NASDAQ Composite ended the session with Clearside Biomedical jumping 7.95% to $3.26 on Thursday while NASDAQ Composite fell 1.71% to $15,517.37.

Volume

Today’s last reported volume for Clearside Biomedical is 393668 which is 22.32% below its average volume of 506822.

Clearside Biomedical’s last close was $3.26, 57.83% below its 52-week high of $7.73.

Clearside Biomedical’s Sales

Clearside Biomedical’s sales growth is 164900% for the ongoing quarter and 8311.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 214.3% and 30.8%, respectively.

Clearside Biomedical’s Revenue

Year-on-year quarterly revenue growth declined by 10.4%, now sitting on 3.9M for the twelve trailing months.

Clearside Biomedical’s Stock Yearly Top and Bottom Value

Clearside Biomedical’s stock is valued at $3.26 at 16:32 EST, way below its 52-week high of $7.73 and way higher than its 52-week low of $1.91.

Clearside Biomedical’s Moving Average

Clearside Biomedical’s value is way below its 50-day moving average of $4.84 and way below its 200-day moving average of $4.37.

More news about Clearside Biomedical.

5. Baudax Bio (BXRX) – 6.56%

NASDAQ Composite ended the session with Baudax Bio rising 6.56% to $0.38 on Thursday while NASDAQ Composite dropped 1.71% to $15,517.37.

Volume

Today’s last reported volume for Baudax Bio is 1361930 which is 18.73% above its average volume of 1147050.

Baudax Bio’s last close was $0.38, 82.17% below its 52-week high of $2.12.

Baudax Bio’s Sales

Baudax Bio’s sales growth is 755.3% for the current quarter and 455.6% for the next. The company’s growth estimates for the present quarter and the next is 72.7% and 51.9%, respectively.

Baudax Bio’s Revenue

Year-on-year quarterly revenue growth grew by 313.2%, now sitting on 756k for the twelve trailing months.

Baudax Bio’s Stock Yearly Top and Bottom Value

Baudax Bio’s stock is valued at $0.38 at 16:32 EST, way under its 52-week high of $2.12 and way higher than its 52-week low of $0.31.

Baudax Bio’s Moving Average

Baudax Bio’s value is way under its 50-day moving average of $0.50 and way under its 200-day moving average of $0.79.

More news about Baudax Bio.

6. Boxlight Corporation (BOXL) – 6%

NASDAQ Composite ended the session with Boxlight Corporation rising 6% to $1.59 on Thursday, after three consecutive sessions in a row of gains. NASDAQ Composite fell 1.71% to $15,517.37, after three successive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Volume

Today’s last reported volume for Boxlight Corporation is 834354 which is 46.62% below its average volume of 1563050.

Boxlight Corporation’s last close was $1.59, 58.16% under its 52-week high of $3.80.

Boxlight Corporation’s Sales

Boxlight Corporation’s sales growth is 26.5% for the present quarter and 23.3% for the next. The company’s growth estimates for the current quarter and the next is 50% and 66.7%, respectively.

Boxlight Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 543.7%, now sitting on 173.05M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Boxlight Corporation’s stock is considered to be oversold (<=20).

Boxlight Corporation’s Stock Yearly Top and Bottom Value

Boxlight Corporation’s stock is valued at $1.59 at 16:32 EST, way below its 52-week high of $3.80 and way higher than its 52-week low of $1.28.

Boxlight Corporation’s Moving Average

Boxlight Corporation’s worth is way under its 50-day moving average of $2.01 and way below its 200-day moving average of $2.29.

More news about Boxlight Corporation.

7. BioXcel Therapeutics (BTAI) – 5.41%

NASDAQ Composite ended the session with BioXcel Therapeutics jumping 5.41% to $23.79 on Thursday while NASDAQ Composite dropped 1.71% to $15,517.37.

Volume

Today’s last reported volume for BioXcel Therapeutics is 296068 which is 0.66% above its average volume of 294112.

BioXcel Therapeutics’s last close was $23.79, 64.88% below its 52-week high of $67.74.

The company’s growth estimates for the ongoing quarter and the next is a negative 27.6% and a negative 17.6%, respectively.

BioXcel Therapeutics’s Stock Yearly Top and Bottom Value

BioXcel Therapeutics’s stock is valued at $23.79 at 16:32 EST, way below its 52-week high of $67.74 and way higher than its 52-week low of $18.82.

BioXcel Therapeutics’s Moving Average

BioXcel Therapeutics’s worth is way under its 50-day moving average of $28.75 and way under its 200-day moving average of $32.29.

More news about BioXcel Therapeutics.

8. Restoration Hardware Holdings (RH) – 5.38%

NYSE Composite ended the session with Restoration Hardware Holdings jumping 5.38% to $608.01 on Thursday, after five sequential sessions in a row of gains. NYSE Composite slid 0.51% to $16,812.98, after three successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Restoration Hardware Holdings is 2043280 which is 385.26% above its average volume of 421066.

Restoration Hardware Holdings’s last close was $576.96, 22.51% under its 52-week high of $744.56.

The company’s growth estimates for the ongoing quarter and the next is 6.3% and 14.4%, respectively.

Restoration Hardware Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 78.3%, now sitting on 3.23B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Restoration Hardware Holdings’s stock is considered to be oversold (<=20).

Restoration Hardware Holdings’s Stock Yearly Top and Bottom Value

Restoration Hardware Holdings’s stock is valued at $608.01 at 16:32 EST, way under its 52-week high of $744.56 and way above its 52-week low of $391.24.

Restoration Hardware Holdings’s Moving Average

Restoration Hardware Holdings’s value is under its 50-day moving average of $662.37 and under its 200-day moving average of $671.97.

More news about Restoration Hardware Holdings.

9. Catalyst Biosciences (CBIO) – 5.08%

NASDAQ Composite ended the session with Catalyst Biosciences jumping 5.08% to $1.24 on Thursday, after three successive sessions in a row of gains. NASDAQ Composite slid 1.71% to $15,517.37, after three consecutive sessions in a row of gains, on what was an all-around negative trend exchanging session today.

Volume

Today’s last reported volume for Catalyst Biosciences is 886160 which is 39.66% above its average volume of 634493.

Catalyst Biosciences ‘s last close was $1.24, 83.58% below its 52-week high of $7.55.

The company’s growth estimates for the current quarter and the next is 31.4% and 39.2%, respectively.

Catalyst Biosciences ‘s Revenue

Year-on-year quarterly revenue growth grew by 157.4%, now sitting on 6.93M for the twelve trailing months.

Catalyst Biosciences ‘s Stock Yearly Top and Bottom Value

Catalyst Biosciences ‘s stock is valued at $1.24 at 16:32 EST, way below its 52-week high of $7.55 and way higher than its 52-week low of $1.04.

Catalyst Biosciences ‘s Moving Average

Catalyst Biosciences ‘s worth is way under its 50-day moving average of $2.83 and way under its 200-day moving average of $4.24.

More news about Catalyst Biosciences .

10. CVS Health (CVS) – 4.88%

NYSE Composite ended the session with CVS Health rising 4.88% to $97.65 on Thursday, after five successive sessions in a row of gains. NYSE Composite dropped 0.51% to $16,812.98, after three consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for CVS Health is 10127700 which is 85.28% above its average volume of 5466150.

CVS Health’s last close was $93.10, 3.59% under its 52-week high of $96.57.

News about CVS Health today

  • Why CVS health shares are rising today. According to today’s article on Benzinga, "As a result, CVS Health updated its 2021 adjusted earnings guidance to "at least $8" per share versus the estimate of $7.98 per share. "
  • CVS health corp.: the winning streak continues. According to today’s article on Benzinga, "Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. ", "In the past 12 month, CVS Health Corp. share prices are bracketed by a low of $67.06 and a high of $97.19 and are now at $96.29, 44% above that low price."

CVS Health’s Sales

CVS Health’s sales growth is 5.5% for the ongoing quarter and 3.3% for the next. The company’s growth estimates for the current quarter and the next is 6.6% and 21.5%, respectively.

CVS Health’s Revenue

Year-on-year quarterly revenue growth grew by 11%, now sitting on 277.29B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

CVS Health’s stock is considered to be oversold (<=20).

CVS Health’s Stock Yearly Top and Bottom Value

CVS Health’s stock is valued at $97.65 at 16:32 EST, above its 52-week high of $96.57.

CVS Health’s Moving Average

CVS Health’s worth is way above its 50-day moving average of $87.21 and way above its 200-day moving average of $84.72.

More news about CVS Health.

Most Active Losers Today

1. Ringcentral (RNG) – -15.54%

NYSE Composite ended the session with Ringcentral dropping 15.54% to $181.18 on Thursday while NYSE Composite dropped 0.51% to $16,812.98.

Volume

Today’s last reported volume for Ringcentral is 2795870 which is 108.39% above its average volume of 1341620.

Ringcentral’s last close was $214.51, 52.22% below its 52-week high of $449.00.

Ringcentral’s Sales

Ringcentral’s sales growth is 29.4% for the current quarter and 25.3% for the next. The company’s growth estimates for the present quarter and the next is 26.9% and 24.1%, respectively.

Ringcentral’s Revenue

Year-on-year quarterly revenue growth grew by 36.4%, now sitting on 1.37B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ringcentral’s stock is considered to be oversold (<=20).

Ringcentral’s Stock Yearly Top and Bottom Value

Ringcentral’s stock is valued at $181.18 at 16:32 EST, way under its 52-week low of $207.53.

Ringcentral’s Moving Average

Ringcentral’s value is way under its 50-day moving average of $233.34 and way under its 200-day moving average of $257.06.

More news about Ringcentral.

2. GameStop (GME) – -11.64%

NYSE Composite ended the session with GameStop falling 11.64% to $153.43 on Thursday while NYSE Composite dropped 0.51% to $16,812.98.

Volume

Today’s last reported volume for GameStop is 3512970 which is 53.95% above its average volume of 2281860.

GameStop’s last close was $173.65, 64.05% under its 52-week high of $483.00.

The company’s growth estimates for the present quarter is 3.8% and a drop 23.9% for the next.

GameStop’s Revenue

Year-on-year quarterly revenue growth grew by 25.1%, now sitting on 5.35B for the twelve trailing months.

GameStop’s Stock Yearly Top and Bottom Value

GameStop’s stock is valued at $153.43 at 16:32 EST, way under its 52-week high of $483.00 and way above its 52-week low of $10.72.

GameStop’s Moving Average

GameStop’s worth is way under its 50-day moving average of $186.36 and way under its 200-day moving average of $190.95.

Previous days news about GameStop

  • Gamestop reports wider loss amid lack of news on strategy. According to Bloomberg Quint on Wednesday, 8 December, "Separately, GameStop said it received a subpoena in August from the Securities and Exchange Commission asking for documents, following up on an initial request in May regarding an investigation by the agency into the trading activity of GameStop’s securities and those of other companies. ", "Pachter, who rates GameStop a sell, is among the three Wall Street analysts who still have ratings on the stock, down from nine a year ago."
  • Gamestop Q3 earnings takeaways: revenue up 29% yoy, inventory ramp, SEC subpoena and more. According to Benzinga on Wednesday, 8 December, "On August 25, 2021, the SEC issued a subpoena calling for additional documents, as a follow up to the inital request," GameStop said.", "Video game retailer GameStop Corp (NYSE: GME) reported third quarter financial results after market close Wednesday."
  • Gamestop earnings report: loss widened last quarter. According to The Wall Street Journal on Wednesday, 8 December, "Despite the lingering pandemic and a shortage of new gaming consoles from Microsoft Corp. and Sony Group Corp., GameStop reported increased hardware and collectibles sales. "

More news about GameStop.

3. Cemtrex (CETXP) – -11.02%

NASDAQ Composite ended the session with Cemtrex sliding 11.02% to $2.10 on Thursday, after four consecutive sessions in a row of losses. NASDAQ Composite dropped 1.71% to $15,517.37, after three consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Volume

Today’s last reported volume for Cemtrex is 1 which is 99.83% below its average volume of 589.

Cemtrex’s last close was $2.10, 35.34% below its 52-week high of $3.25.

Cemtrex’s Revenue

Year-on-year quarterly revenue growth grew by 22.3%, now sitting on 39.17M for the twelve trailing months.

Cemtrex’s Stock Yearly Top and Bottom Value

Cemtrex’s stock is valued at $2.10 at 16:32 EST, way below its 52-week high of $3.25 and way above its 52-week low of $1.44.

Cemtrex’s Moving Average

Cemtrex’s worth is higher than its 50-day moving average of $2.09 and below its 200-day moving average of $2.20.

More news about Cemtrex.

4. Kinross Gold (KGC) – -10.95%

NYSE Composite ended the session with Kinross Gold falling 10.95% to $5.24 on Thursday, after five successive sessions in a row of losses. NYSE Composite dropped 0.51% to $16,812.98, after three sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Kinross Gold is 38475500 which is 195.43% above its average volume of 13023400.

Kinross Gold’s last close was $5.89, 29.38% below its 52-week high of $8.34.

Kinross Gold’s Sales

Kinross Gold’s sales growth is a negative 17.6% for the current quarter and a decline by 17.4% for the next. The company’s growth estimates for the present quarter and the next is a negative 72% and a negative 70.4%, respectively.

Kinross Gold’s Revenue

Year-on-year quarterly revenue growth declined by 0.6%, now sitting on 4.31B for the twelve trailing months.

Kinross Gold’s Stock Yearly Top and Bottom Value

Kinross Gold’s stock is valued at $5.24 at 16:32 EST, way below its 52-week high of $8.34 and higher than its 52-week low of $5.18.

Kinross Gold’s Moving Average

Kinross Gold’s worth is way under its 50-day moving average of $5.88 and way below its 200-day moving average of $6.49.

More news about Kinross Gold.

5. Dare Bioscience (DARE) – -9.62%

NASDAQ Composite ended the session with Dare Bioscience sliding 9.62% to $1.92 on Thursday while NASDAQ Composite fell 1.71% to $15,517.37.

Volume

Today’s last reported volume for Dare Bioscience is 12935700 which is 189.63% above its average volume of 4466170.

Dare Bioscience’s last close was $2.13, 44.68% under its 52-week high of $3.85.

The company’s growth estimates for the ongoing quarter and the next is 57.1% and 18.8%, respectively.

Dare Bioscience’s Stock Yearly Top and Bottom Value

Dare Bioscience’s stock is valued at $1.92 at 16:32 EST, way below its 52-week high of $3.85 and way higher than its 52-week low of $1.10.

Dare Bioscience’s Moving Average

Dare Bioscience’s value is way above its 50-day moving average of $1.64 and way higher than its 200-day moving average of $1.61.

More news about Dare Bioscience.

6. Coinbase (COIN) – -9.06%

NASDAQ Composite ended the session with Coinbase dropping 9.06% to $261.44 on Thursday, after five consecutive sessions in a row of gains. NASDAQ Composite fell 1.71% to $15,517.37, after three sequential sessions in a row of gains, on what was an all-around negative trend exchanging session today.

Volume

Today’s last reported volume for Coinbase is 4161260 which is 17.9% below its average volume of 5068570.

News about Coinbase today

  • Coinbase will integrate hardware wallet ledger in Q1 2022. According to today’s article on Benzinga, "U.S.-based crypto exchange Coinbase Global Inc (NASDAQ:COIN) plans to allowits user to self-custody their crypto assets.", "Max Branzburg, vice president of product at Coinbase said in a statement: "We’re excited to share more announcements on how we’re making Coinbase Wallet the safest and most secure way to participate in Web3 over the coming months."
  • Coinbase launches defi yield product for non-U.S. customers. According to today’s article on Bloomberg Quint, "While Coinbase is a centralized exchange, it has a long-term ambition to bridge its users with the growing world of decentralized finance applications, a philosophy championed by Chief Executive Officer Brian Armstrong. ", "In a company blog on Thursday, Coinbase said the new offering will let customers in over 70 countries to access the "attractive yields" of decentralized finance by depositing their Dai, a stablecoin designed to be pegged to the U.S. dollar, into Compound Finance, a DeFi protocol. "

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Coinbase’s stock is considered to be oversold (<=20).

Previous days news about Coinbase

  • Coinbase COO says company preparing for trading fees compression. According to Bloomberg Quint on Tuesday, 7 December, "We haven’t changed our fee structure on the retail side yet," Coinbase President and COO Emilie Choi said during a Goldman Sachs U.S. Financial Services Conference on Tuesday. ", "DAOs, or decentralized autonomous organizations, is also one area that Coinbase has been closely following."
  • Coinbase global whale trades for December 07. According to Benzinga on Tuesday, 7 December, "Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $250.0 to $395.0 for Coinbase Global over the last 3 months.", "Someone with a lot of money to spend has taken a bullish stance on Coinbase Global (NASDAQ:COIN)."
  • Nextech AR integrates with coinbase commerce, now accepting cryptocurrency as payment method. According to Benzinga on Wednesday, 8 December, "Nextech AR Integrates with Coinbase Commerce, now accepting the following major cryptocurrencies as payment method: Bitcoin, Ethereum, Litecoin, and USD Coin (Graphic: Business Wire)", "With this Coinbase integration Nextech is positioning not only as a metaverse technology company that offers metaverse solutions to its customers but also as an end-to-end metaverse company that accepts crypto, keeping us ahead of the curve in everything we do."

More news about Coinbase.

7. QuantumScape (QS) – -8.1%

NYSE Composite ended the session with QuantumScape falling 8.1% to $24.11 on Thursday, after five sequential sessions in a row of gains. NYSE Composite slid 0.51% to $16,812.98, after three successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for QuantumScape is 7443650 which is 40.34% below its average volume of 12478800.

QuantumScape’s last close was $26.24, 80.23% below its 52-week high of $132.73.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

QuantumScape’s stock is considered to be oversold (<=20).

QuantumScape’s Stock Yearly Top and Bottom Value

QuantumScape’s stock is valued at $24.11 at 16:32 EST, way under its 52-week high of $132.73 and way higher than its 52-week low of $13.71.

QuantumScape’s Moving Average

QuantumScape’s value is under its 50-day moving average of $26.47 and below its 200-day moving average of $25.87.

More news about QuantumScape.

8. VerifyMe (VRME) – -7.34%

NASDAQ Composite ended the session with VerifyMe sliding 7.34% to $3.41 on Thursday while NASDAQ Composite fell 1.71% to $15,517.37.

Volume

Today’s last reported volume for VerifyMe is 23071 which is 54.29% below its average volume of 50479.

VerifyMe’s last close was $3.68, 42.5% under its 52-week high of $6.40.

VerifyMe’s Sales

VerifyMe’s sales growth is 98% for the present quarter and 300% for the next.

VerifyMe’s Revenue

Year-on-year quarterly revenue growth grew by 65.3%, now sitting on 488k for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

VerifyMe’s stock is considered to be oversold (<=20).

VerifyMe’s Stock Yearly Top and Bottom Value

VerifyMe’s stock is valued at $3.41 at 16:32 EST, way below its 52-week high of $6.40 and way higher than its 52-week low of $2.76.

VerifyMe’s Moving Average

VerifyMe’s value is below its 50-day moving average of $3.47 and under its 200-day moving average of $3.66.

More news about VerifyMe.

9. Wayfair (W) – -6.89%

NYSE Composite ended the session with Wayfair sliding 6.89% to $221.58 on Thursday, after five sequential sessions in a row of gains. NYSE Composite fell 0.51% to $16,812.98, after three sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Wayfair is 1122010 which is 18.68% below its average volume of 1379920.

Wayfair’s last close was $237.98, 35.51% under its 52-week high of $369.00.

Wayfair’s Sales

Wayfair’s sales growth is a negative 14.8% for the present quarter and 2.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 99.1% and a negative 63.7%, respectively.

Wayfair’s Revenue

Year-on-year quarterly revenue growth grew by 49.2%, now sitting on 15.29B for the twelve trailing months.

Wayfair’s Stock Yearly Top and Bottom Value

Wayfair’s stock is valued at $221.58 at 16:32 EST, way below its 52-week high of $369.00 and above its 52-week low of $221.09.

Wayfair’s Moving Average

Wayfair’s value is way under its 50-day moving average of $249.99 and way under its 200-day moving average of $283.66.

Previous days news about Wayfair

  • Wayfair adding three stores in 2022. According to MarketWatch on Tuesday, 7 December, "Wayfair began launching pop-up shops in 2018, and has had a standalone Wayfair store since 2019. "
  • Wayfair to open three new stores. According to The Wall Street Journal on Tuesday, 7 December, "Online home-goods seller Wayfair Inc. is making its biggest bet yet on physical retail, as it plans to openthree new bricks-and-mortar locations in Massachusetts next year."

More news about Wayfair.

10. Chiasma (CHMA) – -6%

NASDAQ Composite ended the session with Chiasma falling 6% to $3.76 on Thursday, after three consecutive sessions in a row of losses. NASDAQ Composite dropped 1.71% to $15,517.37, after three consecutive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Volume

Today’s last reported volume for Chiasma is 8196720 which is 722.65% above its average volume of 996380.

Chiasma’s last close was $3.76, 34.49% below its 52-week high of $5.74.

Chiasma’s Stock Yearly Top and Bottom Value

Chiasma’s stock is valued at $3.76 at 16:32 EST, way under its 52-week high of $5.74 and way above its 52-week low of $2.77.

Chiasma’s Moving Average

Chiasma’s worth is way below its 50-day moving average of $4.35 and below its 200-day moving average of $3.86.

More news about Chiasma.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here